Navigation Links
MEI Pharma Announces Pricing of Public Offering of Common Stock
Date:10/25/2013

calling (415) 364-2500, or from Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, New York 11717, Attention: Prospectus Department, or by calling (631) 274-2806, or by faxing (631) 254-7140. An electronic copy of the prospectus supplement and accompanying base prospectus relating to the offering will also be available on the website of the SEC at www.sec.gov.

This release does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About MEI Pharma

MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company's lead drug candidate is Pracinostat, a potential best-in-class, oral HDAC inhibitor being developed for advanced hematologic diseases, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The Company initiated a randomized, placebo-controlled Phase II trial of Pracinostat in combination with Vidaza (azacitidine) in patients with previously untreated MDS in June 2013. An open-label Phase II trial of Pracinostat in combination with Vidaza in elderly patients with AML who are unsuitable for intensive chemotherapy is expected to initiate in the fall of 2013. MEI Pharma is also developing ME-344, a mitochondrial inhibitor derived from its isoflavone-based technology platform. Results from a first-in-human, single-agent clinical study of ME-344 in patients with refractory solid tumors were presented in October 2013. In September 2013, the Company further expanded its pipeline of drug candidates with
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The efficacy of ... highlighted in a recently published study 1 of ... prevention research team, including Curtis Donskey , M.D.  ... run for the same length of time from the ... (PU-UV) unit.  The results showed surprisingly low pathogen kill ...
(Date:3/31/2015)... , March 31, 2015  Frequentz Inc., a global ... a white paper to help the pharmaceutical industry understand ... Supply Chain Security Act (DSCSA). The white paper, "From ... the GS1 EPCIS Standard(s) and Implementation Plan ... the product tracing requirements that need to occur between ...
(Date:3/31/2015)... March 31, 2015  Dr. Renu Razdan of ... World Orphan Drug Congress in April to discuss the latest, ... process and orphan drugs below: India,s ... the Ministry of Health that if a new drug is ... be obtained in India with waiver ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2
(Date:3/31/2015)... Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) ... fraud resulted in $45.4 million in savings -- identified ... -- in 2014. The $45.4 million represents the highest/recovery ... Special Investigations Unit (SIU) in 1983. Since 2005, ... , “Our SIU has progressively enhanced Horizon’s analytics ...
(Date:3/31/2015)... March 31, 2015 An individual’s meniscus ... important ligaments in the leg providing stability, load bearing ... study at today’s Specialty Day meeting of the American ... MRI data to determine the potential for biologic healing ... understood about the healing of meniscus tears when a ...
(Date:3/31/2015)... March 31, 2015 Burns Engineering announces 3-Day ... for the Food & Beverage, Pharmaceutical and Biotech markets. ... are ASME-BPE compliant and are now available as part of ... running. , The S01 and S03 with 1/8” ... Ferrule process connections used in process lines 1/4” and larger. ...
(Date:3/31/2015)... The report “Coagulation/Hemostasis Analyzer Market ... Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, ... analyzes and studies the major market drivers, restraints, ... and the Rest of the world (RoW). ... to reach $3.58 billion by 2019 from $2.4 ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 ... that specializes in providing online solutions to ... today it has achieved full accreditation for ... Network Accreditation Program (HNAP) from the Electronic ... EHNAC’s HNAP accreditation runs in two-year increments ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Burns Engineering Now Offers 3-Day Quick Ship on Sanitary RTDs and Thermocouples 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 3Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 4Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 2Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 3
... Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast: , , ... Friday, August 14, 2009 at 12:00 PM ET, ... Live over the Internet -- Simply log on to the web at the, ... Conference call dial-in phone numbers:, Toll-free from the US: (1 888) ...
... , , INDIANAPOLIS, Aug. 3 ... by Adventist Health System as its exclusive clearinghouse for physicians. ... portal-based clearinghouse/Revenue Cycle Management Services to improve Adventist Health System,s ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090701/RMLOGO ...
... ... Plastic Surgery Societies Reveals Surprising Answers , ... New York, NY and Arlington Heights, IL (Vocus) August 3, 2009 -- What ... person. That,s just one finding from a recent consumer survey conducted on the BeautyforLife ...
... INCLINE VILLAGE, Nev., Aug. 3 PDL BioPharma, Inc. (PDL) ... E. ("Barry") Selick, Ph.D., to the Company,s Board of Directors. , ... and his extensive knowledge of PDL,s humanization technology will allow him ... seek to maximize the value of our antibody humanization patents and ...
... HATBORO, Pa., August 3 InfoLogix, Inc. ... of enterprise mobility solutions for the healthcare and commercial industries, ... healthcare providers, the InfoLogix M24 mobile clinical assistant: a powerful ... patient information at the point-of-care. , , ...
... LITTLE FALLS, N.J., Aug. 3 CANTEL MEDICAL ... Purification subsidiary, has continued the expansion of its water purification and ... Systems Int,l, LLC. G.E.M. designs, builds, installs and services high ... The acquired business had pre-acquisition revenues of approximately $3.5 million. ...
Cached Medicine News:Health News:RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 2Health News:RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 3Health News:How Do Our Attitudes About Beauty Change As We Age? 2Health News:How Do Our Attitudes About Beauty Change As We Age? 3Health News:How Do Our Attitudes About Beauty Change As We Age? 4Health News:PDL BioPharma Elects Barry Selick to Its Board of Directors 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 3Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 2Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 3
The unique design of the TWINFIX Suture Anchors combines high resistance to pullout from our patented thread design with optimal knot tying from the DURABRAID suture....
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... Threaded Anchors (3.0mm) are ideal for soft tissue ... surgical applications. The FASTIN threaded anchor technology offers ... surgical sites. If you need a threaded anchor ... the FASTIN anchor is the anchor for you. ...
Medicine Products: